1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DAS181 for STOP COVID-19 DAS181, Placebo - COVID-19 | Phase 2 / Phase 3 | Withdrawn | Ansun Biopharma, Inc. | 2020-07-25 | 2020-08-11 |
COVID-19 (1) · Coronavirus Infections (1)
Coronaviridae Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1) · Virus Diseases (1)
oplunofusp (1)
Italy (1)